US Cancer Death Rate Dropped for 25 Years Starting in 1991

Better treatment and diagnoses have helped more people survive, but economic disparities in outcomes for some preventable cancers have gotten worse.

Written byCarolyn Wilke
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ABOVE: © ISTOCK.COM,
KCKATE16

The US cancer death rate has steadily dropped since 1991, with a total decline of 27 percent over 25 years, researchers reported yesterday in CA: A Cancer Journal for Clinicians. The deaths from cancer for every 100,000 people dropped from a peak of 215 in 1991 to 156 in 2016. Advances in cancer treatment and detection as well as a decrease in smoking have primarily driven the decrease, according to the authors.

Although cancer was still the second leading killer in 2016, the study revealed a decline in deaths from the four major types of cancer: lung, breast, prostate, and colorectal. Lung cancer is the most deadly, but with fewer people smoking, the death rate among men has fallen by almost 50 percent since 1991, reports The Associated Press.

Death rates due to obesity-related cancers, including uterine, pancreatic, and liver cancers, have been on the rise, although ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies